Patent · US Active

Method of treatment with humanized anti-IL-18 antibodies

US10703814B2 · kind B2 · utility

2Cited by
3References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 16, 2018
Grant dateJul 7, 2020
Priority date
Expiry dateOct 16, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention discloses humanised anti-IL-18 antibodies, methods of manufacture, and methods of treatment with said antibodies. Further disclosed are screening methods using for example surface plasmon resonance to identify antibodies with therapeutic potential.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.